PHARMACOKINETICS, BIO-EQUIVALENCE AND TISSUE RESIDUES OF TWO ORAL COLISTIN FORMULATIONS IN BROILER CHICKENS

Abstract

Objective: The present study was carried out to investigate and provide an overview of the pharmacokinetics, bio-equivalence and tissue residues of colistin in two oral tested products, BAC-Liquido® (Interchemi Co.) and Coline-L® (Medmac Co.) in healthy broiler chickens.Methods: The comparative pharmacokinetics, bio-equivalence, blood and tissue residues of BAC-Liquido® and Coline-L® in broiler chickens was studied after oral administration of both products in a dose of 100.000 IU colistin base/kg. b. wt once daily for 5 consecutive days.Results: Colistin in both products obeyed a two compartments open model following I. V administration. The disposition kinetics of BAC-Liquido® and Coline-L® following oral administration of 100.000 IU colistin base/kg. b. wt revealed that the maximum blood concentration [Cmax.] were 5.10 and 4.95 µg/ml and attained at [tmax.] of 5.90 and 6.40 h, respectively. Colistin in BAC-Liquido® and Coline-L® was eliminated with half-lives [t1/2β] equal to 3.15 and 2.89 h, respectively. The mean systemic bioavailability of colistin in BAC-Liquido® and Coline-L® following oral administration in healthy chickens was 3.75 and 4.05%, respectively. The blood (µg/ml) and tissue (µg/g) residues of Coline-L® and BAC-Liquido® following repeated oral administrations showed that liver, kidney; lung, breast, and thigh muscles contained the limited colistin residues. Colistin in both preparations was completely disappeared from all tissues at 24 h following the last oral dose (except liver 48 h).Conclusion: It was concluded that Coline-L® is bioequivalent to BAC-Liquido® since Cmax test/Cmax reference and AUCtest/AUCreference ratios were 0.97 and 1.06, respectively. Chickens should not be slaughtered for human consumption within treatment and could be consumed after the discontinuation of the treatment (except liver, withdrawal time 48 h) of either BAC-Liquido® or Coline-L®.Keywords: Pharmacokinetics, Colistin, Broiler chickens, Bioavailability, Tissue residue.

Authors and Affiliations

Ahmed M. Soliman, Ahmed Ragab Elbestawy, Sherin Ibrahim

Keywords

Related Articles

ANTIFUNGAL ACTIVITY OF LIPASE MODIFIED FLAVONOIDS FROM CITRUS LIMETTA

Objective: The aim of the present study is to bring about enzymatic modification of flavonoids from Citrus limetta in order to increase their antifungal activity.Methods: Methanolic extraction of flavonoids from citrus p...

MICROWAVE-ASSISTED EXTRACTION OF BIO-ACTIVE COMPOUNDS (PHENOLICS AND ALKAMIDES) FROM ECHINACEA PURPUREA

Objective: Echinacea purpurea is used widely for its unspecific enhancement of the immune system. It contains multiple bioactive substances, including, phenolics (caffeic acid derivatives), flavonoids, anthocyanins and a...

QUANTIFICATION OF EXEMESTANE ACCUMULATION DURING MICROBIAL BIOCONVERSION BY TLC IMAGE ANALYSIS

Objective: The present study was aimed at developing a rapid, cost effective and accurate method for quantification of exemestane using thin layer chromatography (TLC) separation followed by image analysis and to test it...

MICROENCAPSULATION OF PULP OF MANGIFERA INDICA L. BY SPRAY DRYING AND ANTIOXIDANT ACTIVITY

Introduction: For the food industry and trade, it is very important to obtain powders based on fruits or vegetables by means of drying techniques that allow them to preserve their nutritional, organoleptic properties and...

FORMULATION AND EVALUATION OF HERBAL LIPSTICKS FROM CARROT (DAUCUS CAROTA L) EXTRACT

Objective: To prepare and evaluate natural lipsticks made from the standardized extract of carotenoid of carrots (Daucus carota L) with a variety of castor oil base and an irritation test.Methods: The shade-dried coarsel...

Download PDF file
  • EP ID EP577710
  • DOI -
  • Views 36
  • Downloads 0

How To Cite

Ahmed M. Soliman, Ahmed Ragab Elbestawy, Sherin Ibrahim (2016). PHARMACOKINETICS, BIO-EQUIVALENCE AND TISSUE RESIDUES OF TWO ORAL COLISTIN FORMULATIONS IN BROILER CHICKENS. International Journal of Pharmacy and Pharmaceutical Sciences, 8(4), 166-170. https://europub.co.uk/articles/-A-577710